相关实验视频
Updated: May 15, 2025

12:44
The In ovo CAM-assay as a Xenograft Model for Sarcoma
Published on: July 17, 2013
25.4K
在获得专门的肉瘤服务方面存在全球和区域差异
Tomas Zamora1, Eduardo Botello1, Thomas Jenkins2
1Pontificia Universidad Catolica de Chile, Santiago, Chile.
Bone & joint open
|April 10, 2025
概括
全球对肉瘤治疗的准入有很大差异,在低收入地区,专门的中心和先进的治疗方法较少. 这种差异影响了患者的治疗结果,并强调了在癌症治疗中改善全球医疗保健公平的需要.
科学领域:
- 整形瘤学 整形瘤学
- 全球卫生平等全球卫生平等
- 癌症护理差异 癌症护理差异
背景情况:
- 癌症护理指南通常是在先进的医疗系统中制定的,导致医疗保健获得的全球差异.
- 关于获得专门的肉瘤护理的全球数据有限,这阻碍了解决不平等问题的努力.
- 肉瘤护理由于其复杂性,特别容易受到医疗保健获取差异的影响.
研究的目的:
- 在全球范围内对整形瘤科医生进行全面的调查,以了解他们对肉瘤治疗的机会.
- 识别和评估全球和地区在肉瘤诊断和治疗方面的差异.
- 了解医疗保健系统发展和收入分类对肉瘤护理获得的影响.
主要方法:
- 一项25个问题的全球调查分发给参加2024年伯明翰整形瘤会议的骨科瘤学家.
- 受访者提供了有关培训,实践,进入专门的肉瘤中心,诊断技术和治疗方式的数据.
- 为了进行比较分析,各国按地理位置分组,并根据世界银行收入水平进行分类.
主要成果:
- 来自47个国家的192名专家做出了回应,其中40%报告大多数患者在专门的肉瘤中心接受治疗.
- 对诊断技术的获取程度各不相同 (转位研究的69%,免疫组织化学的86%);对质子疗法的获取率很低 (31%).
- 理想的手术管理受到先前治疗 (40%) 和财务限制 (17%) 的影响. 拥有更发达医疗保健系统的地区和国家在所有被调查的方面都表现出更好的获取.
结论:
- 在获得肉瘤护理方面存在重大的全球和区域差异,这可能会影响临床结果.
- 医疗保健系统的发展和国家收入水平与获得肉瘤服务的机会密切相关.
- 进一步的研究对于充分阐明这些差异和为公平的癌症护理策略提供信息至关重要.
相关概念视频
Rous Sarcoma Virus (RSV) and Cancer
4.9K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
4.9K
Cancer Survival Analysis
308
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
308

